A novel isoform ratio switch of the polypyrimidine tract binding protein - PubMed
A novel isoform ratio switch of the polypyrimidine tract binding protein
E J Wagner et al. Electrophoresis. 1999 Apr-May.
Abstract
In this report we present evidence for a novel switch in the ratio of the two major isoforms of the polypyrimidine tract binding protein (PTB) in two related prostate cancer cell lines. The existence of different isoforms of PTB is thought to be the result of alternative splicing. We used UV cross-linking to identify a PTB doublet in the DT3 cell line, which is a rat prostate epithelial cancer line that is androgen-dependent and nonmetastatic. The AT3 cell line, a metastatic, androgen-independent cell line derived from the same tumor as the DT3 cells, was noted here to have a different isoform ratio of PTB. The two most prevalent isoforms of PTB were found to bind to an RNA probe containing a pyrimidine stretch. Western blot analysis demonstrated that these isoforms are indeed expressed differently in the two cell lines and that the observed binding is the result of this differential expression. These two cell lines are derived from the original Dunning prostate tumor, which is a model for studying tumor progression in the prostate. This ratio switch may be an important event in tumor progression in this model system of prostate cancer.
Similar articles
-
Polypyrimidine tract binding protein antagonizes exon definition.
Wagner EJ, Garcia-Blanco MA. Wagner EJ, et al. Mol Cell Biol. 2001 May;21(10):3281-8. doi: 10.1128/MCB.21.10.3281-3288.2001. Mol Cell Biol. 2001. PMID: 11313454 Free PMC article. Review. No abstract available.
-
TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ. Navone NM, et al. Clin Cancer Res. 2000 Mar;6(3):1190-7. Clin Cancer Res. 2000. PMID: 10741751
-
Cornelis S, Tinton SA, Schepens B, Bruynooghe Y, Beyaert R. Cornelis S, et al. Nucleic Acids Res. 2005 May 31;33(10):3095-108. doi: 10.1093/nar/gki611. Print 2005. Nucleic Acids Res. 2005. PMID: 15928332 Free PMC article.
-
Jin W, McCutcheon IE, Fuller GN, Huang ES, Cote GJ. Jin W, et al. Cancer Res. 2000 Mar 1;60(5):1221-4. Cancer Res. 2000. PMID: 10728679
-
Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein.
Sawicka K, Bushell M, Spriggs KA, Willis AE. Sawicka K, et al. Biochem Soc Trans. 2008 Aug;36(Pt 4):641-7. doi: 10.1042/BST0360641. Biochem Soc Trans. 2008. PMID: 18631133 Review.
Cited by
-
Keppetipola NM, Yeom KH, Hernandez AL, Bui T, Sharma S, Black DL. Keppetipola NM, et al. RNA. 2016 Aug;22(8):1172-80. doi: 10.1261/rna.057505.116. Epub 2016 Jun 10. RNA. 2016. PMID: 27288314 Free PMC article.
-
Post-Translational Modifications in Polypyrimidine Tract Binding Proteins PTBP1 and PTBP2.
Pina JM, Reynaga JM, Truong AAM, Keppetipola NM. Pina JM, et al. Biochemistry. 2018 Jul 3;57(26):3873-3882. doi: 10.1021/acs.biochem.8b00256. Epub 2018 Jun 13. Biochemistry. 2018. PMID: 29851470 Free PMC article.
-
Wollerton MC, Gooding C, Robinson F, Brown EC, Jackson RJ, Smith CW. Wollerton MC, et al. RNA. 2001 Jun;7(6):819-32. doi: 10.1017/s1355838201010214. RNA. 2001. PMID: 11421360 Free PMC article.
-
Identification of an intronic splicing enhancer essential for the inclusion of FGFR2 exon IIIc.
Seth P, Miller HB, Lasda EL, Pearson JL, Garcia-Blanco MA. Seth P, et al. J Biol Chem. 2008 Apr 11;283(15):10058-67. doi: 10.1074/jbc.M800087200. Epub 2008 Feb 6. J Biol Chem. 2008. PMID: 18256031 Free PMC article.
-
Polypyrimidine tract binding protein antagonizes exon definition.
Wagner EJ, Garcia-Blanco MA. Wagner EJ, et al. Mol Cell Biol. 2001 May;21(10):3281-8. doi: 10.1128/MCB.21.10.3281-3288.2001. Mol Cell Biol. 2001. PMID: 11313454 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous